South Africa's Aspen plans to buy infant nutritional business from Nestle
JOHANNESBURG (Reuters) - South Africa's Aspen Pharmacare (APNJ.J) has plans to buy Nestle South Africa's infant nutritional business for $215 million, the company said on Thursday.
The deal gives it certain rights to intellectual property licenses, net assets and shares currently conducted by Pfizer.
(Reporting by Sherilee Lakmidas)
(The story corrects value of acquisition)
NEW YORK - With the U.S. Federal Reserve finally announcing it will start tapering its stimulus, removing a big uncertainty in the market, can Wall Street expect a stronger finish to the year? Not really.
WASHINGTON - Start-up companies will be able to raise much more capital through certain public stock deals without facing costly regulatory burdens under a proposal announced by U.S. securities regulators on Wednesday.
BEIJING/HONG KONG - China reiterated its opposition on Thursday to a European Union plan to limit airline carbon dioxide emissions and called for talks to resolve the issue a day after its major airlines refused to pay any carbon costs under the new law.